학술논문

Clinical Utility Cytoplasmic TRBC1 Expression in the Diagnosis and Minimal Residual.
Document Type
Article
Source
Indian Journal of Medical & Paediatric Oncology. 2022 Supplement, Vol. 43, pS1-S19. 19p.
Subject
*DIAGNOSIS
*T-cell lymphoma
Language
ISSN
0971-5851
Abstract
Correspondence to: docprt@gmail.com I Background: i TRBC1 is a novel flow cytometry-based T-cell colonialist marker. I Results: i We studied cytoplasmic TRBC1 expression in eight childhood TALLs (median age = 6 years), 12 adult TALLs (median age = 25 years), and 4 T-ALL MRD samples. I Conclusion: i Our study demonstrates that flow cytometric immunophenotyping of surface and cytoplasmic TRBC1 can aid in detection of abnormal blasts in T-ALL cases and has a high potential in T-ALL MRD monitoring. [Extracted from the article]